Odense University Hospital
Colorectal cancer treated with oxaliplatin and capecitabine
Published in Hospital Law Weekly, March 30th, 2006
According to recent research from Denmark, "The efficacy of XELOX as second-line therapy in patients with advanced colorectal cancer (ACRC) resistant to irinotecan is not well established."
"Oxaliplatin induces acute, cold-induced neuropathy in most patients," acknowledged P. Pfeiffer and colleagues, Odense University Hospital. "The incidence is claimed to be infusion rate-dependent and therefore a 2-h infusion is recommended. For practical and economic reasons, but also for patient's convenience, we performed a phase II...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2006-03-30)
More Articles from Hospital Law Weekly
- Environmental Health
Elderly have higher risk for cardiovascular, respiratory disease from fine particle pollution - Hospital Bicetre, Le Kremlin Bicetre
Echinococcus multilocularis-induced liver infection detected in France - Radlink, Inc.
A. Redmond Doms, Jr. joins Radlink board of directors - Royal Brompton Hospital, London
Angina investigations and therapy are affected by gender bias - Southampton General Hospital
Antipsychotic medication does not necessarily induce diabetes - Baxa, Ltd.
Baxa automated pharmacy production equipment displayed at European meeting - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
